Evaluation of two short tandem repeat multiplex systems for post-haematopoietic stem cell transplantation chimerism analysis
- PMID: 17384881
Evaluation of two short tandem repeat multiplex systems for post-haematopoietic stem cell transplantation chimerism analysis
Abstract
Introduction: The follow-up of chimerism status after allogeneic haematopoietic stem cell transplantation (HSCT) is essential to predict successful engraftment to assess the development of graft-versus-host disease, graft rejection and disease relapse. Analysis of short tandem repeats (STR) via polymerase chain reaction is frequently used for chimerism determination. However, most commercially-available kits have been designed for forensic purposes and may not be optimal for chimerism analysis. The present study aims to identify suitable STR markers for patient-donor pairs of predominantly Malay and Chinese ethnicity using two commercially-available forensic kits.
Methods: We analysed six STR loci, namely, CSF1PO, TPOX, TH01 (using the CTT multiplex system) and F13A01, FESFPS and vWA (using the FFv multiplex system) in 33 human leukocyte antigen-matched Malaysian patient-donor pairs to determine the suitability of these two multiplex systems for chimerism analysis in our local population.
Results: Informativity (different alleles in donor and recipient) of each individual locus was TH01 73 percent, vWA 73 percent, F13A01 52 percent, CSF1PO 61 percent, FESFPS 39 percent and TPOX 45 percent. When combined, the six STR loci were able to give chimerism results in 31 out of 33 (94 percent) cases.
Conclusion: We found that TH01 and vWA are informative STR targets for post-HSCT chimerism analysis in predominantly Malay and Chinese patient-donor pairs. The commercially-available kits will also permit laboratories without extensive molecular biology capabilities to perform DNA typing in HSCT recipients.
Similar articles
-
Multiplex STR panel for assessment of chimerism following hematopoietic stem cell transplantation (HSCT).Ann Hematol. 2019 May;98(5):1279-1291. doi: 10.1007/s00277-019-03626-w. Epub 2019 Feb 19. Ann Hematol. 2019. PMID: 30783731 Clinical Trial.
-
Chimerism detection by short tandem repeat analysis when donor and recipient genotypes are not known.Clin Chim Acta. 2012 Mar 22;413(5-6):548-51. doi: 10.1016/j.cca.2011.11.022. Epub 2011 Nov 29. Clin Chim Acta. 2012. PMID: 22155342
-
Evaluation of STR informativity for chimerism testing--comparative analysis of 27 STR systems in 203 matched related donor recipient pairs.Leukemia. 2004 Feb;18(2):248-54. doi: 10.1038/sj.leu.2403212. Leukemia. 2004. PMID: 14671648
-
Can novel methods replace the gold standard chimerism method after allogeneic hematopoietic stem cell transplantation?Ann Hematol. 2024 Apr;103(4):1035-1047. doi: 10.1007/s00277-023-05448-3. Epub 2023 Oct 6. Ann Hematol. 2024. PMID: 37801085 Review.
-
Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility.Bone Marrow Transplant. 2007 Mar;39(5):255-68. doi: 10.1038/sj.bmt.1705576. Epub 2007 Jan 29. Bone Marrow Transplant. 2007. PMID: 17262064 Review.
Cited by
-
Chimerism Monitoring Techniques after Hematopoietic Stem Cell Transplantation: An Overview of the Last 15 Years of Innovations.Diagnostics (Basel). 2021 Mar 30;11(4):621. doi: 10.3390/diagnostics11040621. Diagnostics (Basel). 2021. PMID: 33808342 Free PMC article. Review.
-
Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation.Sao Paulo Med J. 2009 Sep;127(5):251-8. doi: 10.1590/s1516-31802009000500002. Sao Paulo Med J. 2009. PMID: 20169272 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources